Browsing Tag
Matrix-M
2 posts
Sanofi taps Novavax’s Matrix-M for flu: Is NVAX stock finally turning a corner?
Novavax (NASDAQ: NVAX) expands Sanofi partnership, granting rights to Matrix-M adjuvant for pandemic flu candidates. See stock impact and outlook.
September 30, 2025
Novavax shares rally after FDA approves non-mRNA COVID-19 vaccine for at-risk groups
Novavax stock surged 25% after FDA approved its non-mRNA COVID-19 vaccine Nuvaxovid. Find out what triggered this rally and what it means for investors.
May 19, 2025